Joel A Sincavage

Array ( [id] => 4826840 [patent_doc_number] => 20080125384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'SIMULTANEOUS SILENCING AND RESTORATION OF GENE FUNCTION' [patent_app_type] => utility [patent_app_number] => 11/562281 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4816 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125384.pdf [firstpage_image] =>[orig_patent_app_number] => 11562281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480808 [patent_doc_number] => 20090203765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'MODULATION OF EIF4E-BP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/094598 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203765.pdf [firstpage_image] =>[orig_patent_app_number] => 12094598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239200 [patent_doc_number] => 08603991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Individualized cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/601431 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 17409 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 328 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11601431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056914 [patent_doc_number] => 20070059836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Compositions and methods for regulating genes of interest' [patent_app_type] => utility [patent_app_number] => 11/595104 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6775 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059836.pdf [firstpage_image] =>[orig_patent_app_number] => 11595104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314860 [patent_doc_number] => 07524830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Decoy-containing pharmaceutical compositions and method of using the same' [patent_app_type] => utility [patent_app_number] => 11/580748 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7476 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524830.pdf [firstpage_image] =>[orig_patent_app_number] => 11580748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477390 [patent_doc_number] => 07906490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Circular DNA vectors for synthesis of RNA and DNA' [patent_app_type] => utility [patent_app_number] => 11/523884 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 28647 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906490.pdf [firstpage_image] =>[orig_patent_app_number] => 11523884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983428 [patent_doc_number] => 20070087987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Modulation of glucagon receptor expression' [patent_app_type] => utility [patent_app_number] => 11/524041 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14775 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087987.pdf [firstpage_image] =>[orig_patent_app_number] => 11524041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164506 [patent_doc_number] => 08173612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis' [patent_app_type] => utility [patent_app_number] => 11/521843 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3108 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173612.pdf [firstpage_image] =>[orig_patent_app_number] => 11521843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682815 [patent_doc_number] => 20080249041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512725 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10784 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249041.pdf [firstpage_image] =>[orig_patent_app_number] => 11512725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107677 [patent_doc_number] => 20070066555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512728 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10590 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066555.pdf [firstpage_image] =>[orig_patent_app_number] => 11512728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172386 [patent_doc_number] => 20070072819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512730 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10774 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072819.pdf [firstpage_image] =>[orig_patent_app_number] => 11512730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172387 [patent_doc_number] => 20070072820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512735 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10787 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072820.pdf [firstpage_image] =>[orig_patent_app_number] => 11512735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460770 [patent_doc_number] => 07879811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/510498 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 10793 [patent_no_of_claims] => 153 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879811.pdf [firstpage_image] =>[orig_patent_app_number] => 11510498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136474 [patent_doc_number] => 20070078103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/510496 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10774 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078103.pdf [firstpage_image] =>[orig_patent_app_number] => 11510496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077027 [patent_doc_number] => 07615540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/510280 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 10784 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615540.pdf [firstpage_image] =>[orig_patent_app_number] => 11510280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496474 [patent_doc_number] => 20090264502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HSP27' [patent_app_type] => utility [patent_app_number] => 12/064330 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8120 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264502.pdf [firstpage_image] =>[orig_patent_app_number] => 12064330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242872 [patent_doc_number] => 20070021367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Modulation of SOCS-3 expression' [patent_app_type] => utility [patent_app_number] => 11/505720 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21334 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021367.pdf [firstpage_image] =>[orig_patent_app_number] => 11505720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6579740 [patent_doc_number] => 20100273997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Ribozyme to cleave coronavirus gene' [patent_app_type] => utility [patent_app_number] => 11/501049 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4786 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273997.pdf [firstpage_image] =>[orig_patent_app_number] => 11501049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887671 [patent_doc_number] => 20060275300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/498250 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 39700 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275300.pdf [firstpage_image] =>[orig_patent_app_number] => 11498250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32713 [patent_doc_number] => 07790694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Antisense antibacterial method and compound' [patent_app_type] => utility [patent_app_number] => 11/487009 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 18757 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790694.pdf [firstpage_image] =>[orig_patent_app_number] => 11487009 [rel_patent_id] =>[rel_patent_doc_number] =>)